Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.
Secretory meningiomas constitute a relatively rare subtype of meningiomas, accounting for only 1.1% at our institution, with a 6:1 predominance of female patients. This study aimed to obtain more information about the immunohistochemical characteristics of this histological entity, and to analyse the effects of histological factors such as the presence of mast cells on the radiological evidence of surrounding tumour oedema that frequently occurred in this subtype of meningioma. Fourteen cases of secretory meningioma were examined. Relevant clinical information was obtained from the patient files. Peritumoural oedema was determined either by CT or MRI scans and graded as small, moderate and severe. In order to perform the quantitative evaluation of mast cells in secretory meningiomas in a comparison with other meningiomas, 14 non-secretory meningiomas were randomly selected and used as a control group. The immunohistochemical staining of carcinoembryonic antigen was positive within the secretory droplets and the cells surrounding them in all cases. Ki 67 (MIB 1) proliferative index mean values were 2.4%, indicating low expression in all secretory meningiomas. Moreover, from our statistical analysis, there is no clear-cut pattern of various types of cytokeratins emerging in secretory meningiomas. The secretory meningiomas were characterized by a significantly increased number of mast cells as compared with non-secretory meningiomas of different grades. As the present clinical findings and laboratory results could not confirm a correlation between mast cell density and radiological evidence of oedema, further studies of mediators are warranted.
Tirakotai
Wuttipong
W
Department of Neurosurgery, Philipps University, Baldingerstrasse, 35033 Marburg, Germany.
Mennel
Hans-Dieter
HD
Celik
Ilhan
I
Hellwig
Dieter
D
Bertalanffy
Helmut
H
Riegel
Thomas
T
D000199:Actins / Q000032:analysis; D000328:Adult; D000368:Aged; D001929:Brain Edema / Q000453:epidemiology / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002465:Cell Movement; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D015994:Incidence; D007633:Keratins / Q000032:analysis; D019394:Ki-67 Antigen / Q000032:analysis; D008297:Male; D008407:Mast Cells / Q000737:chemistry* / Q000473:pathology* / Q000502:physiology; D008577:Meningeal Neoplasms / Q000737:chemistry* / Q000453:epidemiology / Q000276:immunology* / Q000473:pathology; D008579:Meningioma / Q000737:chemistry* / Q000453:epidemiology / Q000276:immunology* / Q000473:pathology; D008875:Middle Aged; D018396:Mucin-1 / Q000032:analysis; D020286:Pericytes / Q000473:pathology; D014746:Vimentin / Q000032:analysis
D000199:Actins; D002272:Carcinoembryonic Antigen; D019394:Ki-67 Antigen; D018396:Mucin-1; D014746:Vimentin; D007633:Keratins